Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
54,711,345
-
Total 13F shares
-
14,186,934
-
Share change
-
+14,186,934
-
Total reported value
-
$408,011,450
-
Price per share
-
$29.17
-
Number of holders
-
46
-
Value change
-
+$408,011,278
-
Number of buys
-
46
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) as of Q2 2019
As of 30 Jun 2019,
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,186,934 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, RA CAPITAL MANAGEMENT, LLC, Redmile Group, LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, MILLENNIUM MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, and JANUS HENDERSON GROUP PLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.